Exact Mass: 438.2922
Exact Mass Matches: 438.2922
Found 500 metabolites which its exact mass value is equals to given mass value 438.2922
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPA(0:0/18:0)
LysoPA(0:0/18:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
LysoPA(18:0/0:0)
LysoPA(18:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
2-[[3-Cyclohexyl-1-[2-[3-(diaminomethylideneamino)propylcarbamoyl]piperidin-1-yl]-1-oxopropan-2-yl]amino]acetic acid
1-[(2R)-2-(1,3-Benzodioxol-4-yl)heptyl]-3-[2,6-di(propan-2-yl)phenyl]urea
DG(2:0/20:3(6,8,11)-OH(5)/0:0)
DG(2:0/20:3(6,8,11)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(6,8,11)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:3(6,8,11)-OH(5)/2:0/0:0)
DG(20:3(6,8,11)-OH(5)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(6,8,11)-OH(5)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/20:3(6,8,11)-OH(5))
DG(2:0/0:0/20:3(6,8,11)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:3(6,8,11)-OH(5)/0:0/2:0)
DG(20:3(6,8,11)-OH(5)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Calcium dodecanoate
It is used in foods as a binder, emulsifier and anticaking agent.
ent-13S-Hydroxy-14R,15-diacetoxy-1(10)-halimen-18-oic acid
3-[4,8-Bis[(acetyloxy)methyl]-13-hydroxy-12-methyl-11-tridecenyl]-2(5H)-furanone
ent-13R-Hydroxy-14S,15-diacetoxy-1(10)-halimen-18-oic acid
(20S)-20-(N,N-dimethylamino)-3-(tigloylamino)-pregn-2,5-diene-4-one|2,3-dehydrosarsalignone
stemodin 13-O-alpha-L-arabinopyranoside|stemodinoside A
8, 18-Di-Ac-(4beta, 8alpha, 9alpha, 14beta)-3(16)-Fusicoccene-4, 8, 9, 14, 18-pentol|Fusicoplagin A
(20S)-20-(N,N-dimethylamino)-3-(tigloylamino)-5alpha-pregna-2,14-diene-4-one|14,15-dehydrosarcovagine-D
16-acetoxy-9,13-epoxy-3,18-isopropylidenedioxy-labdan-15-ol
20-hydroxy-1-oxo-(22R)-witha-2,5,24-trienolide|20alphaF-hydroxy-1-oxo-20R,22R-witha-2,5,24-trienolide|20??-Hydroxy-1-oxo-(22R)-witha-2,5,24-trienolide
1-[5-geranyloxy-7-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-2H-chromen-8-yl]ethanone
2,7,8-trimethyl-2-[(3E,7Z)-4,12-dimethyl-8-carboxyl-3,7,11-tridecatrienyl]-3-chromen-6-ol|7-methyl-sargachromenol
3,22beta-dihydroxy-24,29-dinor-1(10),3,5-friedelatriene-2,21-dione
13,17-dihydroxy-labda-8,14-diene-17-O-xylopyranoside
(2E,9Z,16E)-2-tetradeca-5c,12t-diene-8,10-diynyl-octadeca-2,9,16-triene-12,14-diynal
2alpha-(2,3-dihydroxy-2-methylbutyryloxy)-labd-7-en-15-oic acid|2alpha-<2,3-dihydroxy-2-methylbutyryloxy>-labd-7-en-15-oic acid
4alpha-methyl-(24E)-ergosta- 8(9),24(25)-diene-3,11-dione-26-aldehyde|antcamphin C
(3alpha,7beta,9alpha,8alpha,15alpha)-3-(acetyloxy)-9,13:15,16-diepoxy-15-ethoxy-7-hydroxylabdan-6-one|rel-(1R,2S,2R,3R,4aS,5S,6R,8aS)-6-(acetyloxy)-5-ethoxydodecahydro-3-hydroxy-2,5,5,8a;-tetramethyldispiro[furan-3(2H),2(5H)-furan-5,1(4H)-naphthalen]-4-one
2alpha-hydroxy-3alpha-(2-hydroxy 2-methylbutyryloxy)cativic acid
2-Angeloyl-(2beta,3beta,4alpha,13R)-2,3,4-Trihydroxy-15-clerodanoic acid
Ala His Ile Val
Ala His Leu Val
Ala His Val Ile
Ala His Val Leu
Ala Ile His Val
Ala Ile Val His
Ala Leu His Val
Ala Leu Val His
Ala Val His Ile
Ala Val His Leu
Ala Val Ile His
Ala Val Leu His
Gly His Ile Ile
Gly His Ile Leu
Gly His Leu Ile
Gly His Leu Leu
Gly Ile His Ile
Gly Ile His Leu
Gly Ile Ile His
Gly Ile Leu His
Gly Leu His Ile
Gly Leu His Leu
Gly Leu Ile His
Gly Leu Leu His
His Ala Ile Val
His Ala Leu Val
His Ala Val Ile
His Ala Val Leu
His Gly Ile Ile
His Gly Ile Leu
His Gly Leu Ile
His Gly Leu Leu
His Ile Ala Val
His Ile Gly Ile
His Ile Gly Leu
His Ile Ile Gly
His Ile Leu Gly
His Ile Val Ala
His Leu Ala Val
His Leu Gly Ile
His Leu Gly Leu
His Leu Ile Gly
His Leu Leu Gly
His Leu Val Ala
His Val Ala Ile
His Val Ala Leu
His Val Ile Ala
His Val Leu Ala
Ile Ala His Val
Ile Ala Val His
Ile Gly His Ile
Ile Gly His Leu
Ile Gly Ile His
Ile Gly Leu His
Ile His Ala Val
Ile His Gly Ile
Ile His Gly Leu
Ile His Ile Gly
Ile His Leu Gly
Ile His Val Ala
Ile Ile Gly His
Ile Ile His Gly
Ile Ile Pro Pro
Ile Leu Gly His
Ile Leu His Gly
Ile Leu Pro Pro
Ile Pro Ile Pro
Ile Pro Leu Pro
Ile Pro Pro Ile
Ile Pro Pro Leu
Ile Val Ala His
Ile Val His Ala
Leu Ala His Val
Leu Ala Val His
Leu Gly His Ile
Leu Gly His Leu
Leu Gly Ile His
Leu Gly Leu His
Leu His Ala Val
Leu His Gly Ile
Leu His Gly Leu
Leu His Ile Gly
Leu His Leu Gly
Leu His Val Ala
Leu Ile Gly His
Leu Ile His Gly
Leu Ile Pro Pro
Leu Leu Gly His
Leu Leu His Gly
Leu Leu Pro Pro
Leu Pro Ile Pro
Leu Pro Leu Pro
Leu Pro Pro Ile
Leu Pro Pro Leu
Leu Val Ala His
Leu Val His Ala
Pro Ile Ile Pro
Pro Ile Leu Pro
Pro Ile Pro Ile
Pro Ile Pro Leu
Pro Leu Ile Pro
Pro Leu Leu Pro
Pro Leu Pro Ile
Pro Leu Pro Leu
Pro Pro Ile Ile
Pro Pro Ile Leu
Pro Pro Leu Ile
Pro Pro Leu Leu
Val Ala His Ile
Val Ala His Leu
Val Ala Ile His
Val Ala Leu His
Val His Ala Ile
Val His Ala Leu
Val His Ile Ala
Val His Leu Ala
Val Ile Ala His
Val Ile His Ala
Val Leu Ala His
Val Leu His Ala
(5Z,7E,17Z)-(1S,3R)-26,27-dimethyl-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol
(5Z,7E)-(1S,3R)-26,27-dimethyl-9,10-seco-5,7,10(19),20-cholestatetraen-22-yne-1,3,25-triol
3beta-(3-methyl-butanoyloxy)-villanovane-13alpha,17-diol
(17Z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydrovitamin D3
1alpha,25-dihydroxy-26,27-dimethyl-20,21,22,22,23,23-hexadehydrovitamin D3
2,4-Di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate
ethyldimethyl[3-[(1-oxododecyl)amino]propyl]ammonium ethyl sulphate
TERT-BUTYL 4-((TERT-BUTYLDIPHENYLSILYL)OXY)CYCLOHEXANECARBOXYLATE
1,3-diisocyanato-2-methylbenzene,2-ethylhexan-1-ol,2-ethyl-2-(hydroxymethyl)propane-1,3-diol
Veledimex
C308 - Immunotherapeutic Agent > C210 - Immunoadjuvant > C2141 - Chemo Immunostimulant Adjuvant C2140 - Adjuvant
1-Palmityl-2-acetyl-sn-glycero-3-phosphate
A 1-alkyl-2-acyl-sn-glycerol 3-phosphate in which the alkyl and the acyl groups at positions 1 and 2 are specified as hexadecyl and acetyl respectively.
[(2R)-3-hydroxy-2-(octadecanoyloxy)propoxy]phosphonic acid
(17Z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydrovitamin D3/(17Z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydrocholecalciferol
1alpha,25-dihydroxy-26,27-dimethyl-20,21,22,22,23,23-hexadehydrovitamin D3/1alpha,25-dihydroxy-26,27-dimethyl-20,21,22,22,23,23-hexadehydrocholecalciferol
(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-(2,2-dimethylbutanoyloxy)-6-hydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
[(2S)-1-acetyloxy-3-hydroxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2S)-2-acetyloxy-3-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2R)-3-acetyloxy-2-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2S)-3-acetyloxy-2-hydroxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[3-carboxy-2-[(9Z,12Z,15Z)-3-hydroxyoctadeca-9,12,15-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(9Z,11E,15E)-9-hydroxyoctadeca-9,11,15-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(9E,12E,15E)-17-hydroxyoctadeca-9,12,15-trienoyl]oxypropyl]-trimethylazanium
[3-Carboxy-2-[9-(3,4-dimethyl-5-propylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium
[3-carboxy-2-[(6E,9E)-11-(3-pentyloxiran-2-yl)undeca-6,9-dienoyl]oxypropyl]-trimethylazanium
[3-Carboxy-2-[7-(5-heptylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[8-(5-hexylfuran-2-yl)octanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[9-(5-pentylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium
[2-[9-(5-Butyl-3-methylfuran-2-yl)nonanoyloxy]-3-carboxypropyl]-trimethylazanium
[3-carboxy-2-[8-[3-[(2E,5E)-octa-2,5-dienyl]oxiran-2-yl]octanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[7-(3,4-dimethyl-5-pentylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium
Tritoniopsin B, rel-
A natural product found in Tritoniopsis elegans and Cladiella krempfi.
2-(2-methoxyethyl)-9-methyl-N-[3-(4-methyl-1-piperidinyl)propyl]-1-oxo-4-pyrido[3,4-b]indolecarboxamide
(1R)-N-cyclopentyl-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1S)-N-cyclopentyl-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
2-[[(2R)-2-acetyloxy-3-dec-9-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
3beta,4beta,7alpha,12alpha-Tetrahydroxy-5beta-cholan-24-oic acid Methyl ester
[2-(Hexanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate
(2-Acetamido-3-hydroxytridecyl) 2-(trimethylazaniumyl)ethyl phosphate
[2-(Butanoylamino)-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(propanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptanoylamino)-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
3alpha,4beta,7alpha,12alpha-Tetrahydroxy-5beta-cholan-24-oic acid Methyl ester
(E.E)-(1R,2S,5R)-8-beta-Naphthylmenthyl-5-phenyl-2,4-pentadienoate
2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
1-Stearoyl-sn-glycero-3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as stearoyl (octadecanoyl).
lysophosphatidic acid 18:0
A lysophosphatidic acid in which the acyl group (position not specified) contains 18 carbons and no double bonds.
LSM(16:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LPEt(16:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
ethyl 2-[2-(acetyloxy)-12-hydroxy-1,5,12-trimethyl-6,16-dioxatricyclo[11.2.1.0⁵,⁷]hexadecan-9-yl]prop-2-enoate
6-(1-{6-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
1-[(2r)-5-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-7-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-8-yl]ethanone
5'-[(2e)-4-(5-hydroxy-2-methoxy-3-methylphenyl)but-2-en-2-yl]-3'a,5,5,7'a-tetramethyl-2',3',5',7'-tetrahydro-1'h-spiro[furan-2,4'-inden]-6'-one
1-[1,2-bis(acetyloxy)-5-oxocyclopent-3-en-1-yl]tridecyl acetate
(1s,5r,6r,9r,10r,13r,14s,20r,23r)-23-hydroxy-10-isopropyl-1,6,9,14-tetramethyl-21-oxahexacyclo[18.2.1.0²,¹⁸.0⁵,¹⁷.0⁶,¹⁴.0⁹,¹³]tricosa-2(18),16-dien-22-one
(1s,5s,6r,8as)-5-[(3r,4s)-4,5-bis(acetyloxy)-3-hydroxy-3-methylpentyl]-1,5,6-trimethyl-2,3,6,7,8,8a-hexahydronaphthalene-1-carboxylic acid
(1r,9ar,9br,11ar)-1-[(2r,5s)-5-hydroperoxy-5-isopropylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(1s,3as,5ar,9ar,9br,11as)-1-[(1e)-3-[(2r)-3,3-dimethyloxiran-2-yl]-3-oxoprop-1-en-1-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(5r,6s,7r,9s,12r,13s)-12-hydroxy-7-[(1s,2r)-1-hydroxy-2,3-dimethylbutyl]-6,13-dimethylpentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-1,17,19-triene-11,16-dione
4-oxo-4-{[(2r,3r,4e,6s,8e,10e,12e,15r,16s)-6,15,16-trihydroxy-3,5-dimethyloctadeca-4,8,10,12-tetraen-2-yl]oxy}butanoic acid
(1'r,2s,3r,4s,7's,14's,15'r,16's)-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁴,⁹]icosane]-2',4'(9'),10',12'-tetraene-3,7'-diol
(1r,2s,6s,7s,8s,9s,12r,13r,14r)-13,14-dihydroxy-6-isopropyl-12-methoxy-9,13-dimethyl-3-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate
(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 2-methylpropanoate
(6ar,6bs,7r,8as,12ar,14as,14br)-2,7-dihydroxy-4,6a,6b,11,11,14b-hexamethyl-5,6,7,8a,9,10,12,12a,14,14a-decahydropicene-3,8-dione
(2r,3s,4s,5s)-2-{[(1r,2s,4s,7s,10s,12s,13s)-4-hydroxy-2,6,6,13-tetramethyltetracyclo[10.3.1.0¹,¹⁰.0²,⁷]hexadecan-13-yl]oxy}-5-(hydroxymethyl)oxolane-3,4-diol
(4ar,4br,6ar,7r,10ar)-4a,6a-dimethyl-7-[(2r,5r)-4,5,6-trimethylhept-3-en-2-yl]-3h,4h,4bh,5h,6h,7h,8h,9h,11h-indeno[1,7a-a]naphthalene-2,10,12-trione
(2s)-3-[(1r,2s,4as,4br,8ar,10as)-2-hydroxy-2,4b,8,8,10a-pentamethyl-decahydrophenanthrene-1-carbonyloxy]-2-hydroxypropyl acetate
1-[6-(acetyloxy)-3-hydroxy-7-methyl-4-methylidene-octahydro-1h-naphtho[4,4a-c]furan-7-yl]-4-hydroxy-4-methylpentan-3-yl acetate
(6r,7e,10r,14s)-14-(6,8-dihydroxy-2-methylidenenonyl)-6,10-dihydroxy-8-methyl-12-methylidene-1-oxacyclotetradec-7-en-2-one
(2s)-2-[4-hydroxy-2-({[(2s)-2-[4-hydroxy-2-(hydroxymethyl)but-1-en-1-yl]-5-methylhex-4-enoyl]oxy}methyl)but-1-en-1-yl]-5-methylhex-4-enoic acid
7-[(2e)-5-[(1r,2s,4ar,8as)-5-(hydroxymethyl)-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl]-6-amino-9-methyl-8h-purin-8-yl
6-{[2-(4a-methyl-8-methylidene-octahydronaphthalen-2-yl)propan-2-yl]oxy}-4-(acetyloxy)-5-hydroxyoxan-3-yl acetate
(1r,2r,3s,5s,7r,8r,10s,11s,14r)-14-(acetyloxy)-5,10-dihydroxy-3-isopropyl-10,14-dimethyl-6-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-11-yl acetate
20β-hydroxy-1-oxo-(22r)-witha-2,5,24-tri-enolide
{"Ingredient_id": "HBIN003390","Ingredient_name": "20\u03b2-hydroxy-1-oxo-(22r)-witha-2,5,24-tri-enolide","Alias": "NA","Ingredient_formula": "C28H38O4","Ingredient_Smile": "CC1=C(C(=O)OC(C1)C(C)(C2CCC3C2(CCC4C3CC=C5C4(C(=O)C=CC5)C)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9742","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
27-hydroxy-3-oxo-witha-1,4,24-trienolide
{"Ingredient_id": "HBIN005032","Ingredient_name": "27-hydroxy-3-oxo-witha-1,4,24-trienolide","Alias": "NA","Ingredient_formula": "C28H38O4","Ingredient_Smile": "CC1=C(C(=O)OC(C1)C(C)C2CCC3C2(CCC4C3CCC5=CC(=O)C=CC45C)C)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10586","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}